Expression of the survivin gene in prostate cancer: Relation to the PSA doubling time and pathological factors

被引：0
|
作者：
Kishi, H
Kikuno, N
Yoshino, T
Urakami, S
Shiina, H
Igawa, M
机构：
来源：
JOURNAL OF UROLOGY | 2003年 / 169卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
812
引用
收藏
页码：210 / 210
页数：1
相关论文
共 50 条
  • [41] PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer
    Roberts, SG
    Blute, ML
    Bergstralh, EJ
    Slezak, JM
    Zincke, H
    MAYO CLINIC PROCEEDINGS, 2001, 76 (06) : 576 - 581
  • [42] PSA splice variants and their expression in prostate cancer
    Yang, Alice S.
    Alahapperuma, Thushari
    Mubiru, James N.
    Garcia-Forey, Magdalena
    Shade, Robert E.
    CANCER RESEARCH, 2014, 74 (19)
  • [43] Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
    Spiess, Philippe E.
    Lee, Andrew K.
    Leibovici, Dan
    Wang, Xuemei
    Do, Kim-Anh
    Pisters, Louis L.
    CANCER, 2006, 107 (02) : 275 - 280
  • [44] PSA Doubling Time Versus PSA Velocity to Predict High-Risk Prostate Cancer: Data from the Baltimore Longitudinal Study of Aging
    Loeb, Stacy
    Kettermann, Anna
    Ferrucci, Luigi
    Landis, Patricia
    Metter, E. Jeffrey
    Carter, H. Ballentine
    EUROPEAN UROLOGY, 2008, 54 (05) : 1073 - 1080
  • [45] PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
    Markowski, Mark C.
    Chen, Yongmei
    Feng, Zhaoyong
    Cullen, Jennifer
    Trock, Bruce J.
    Suzman, Daniel
    Antonarakis, Emmanuel S.
    Paller, Channing J.
    Rosner, Inger
    Han, Misop
    Walsh, Patrick C.
    Partin, Alan W.
    Eisenberger, Mario
    CLINICAL GENITOURINARY CANCER, 2019, 17 (06) : 470 - +
  • [46] Prognostic factors in men receiving androgen deprivation therapy (ADT) for recurrent prostate cancer: Using absolute PSA and PSA doubling time (DT) to guide timing of ADT initiation.
    Ravi, Praful Kumar
    Karnes, Jeffrey
    Rangel, Laureano J.
    Pagliaro, Lance C.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [47] Novel polymorphisms of prostate-specific antigen (PSA) gene associated with PSA mRNA expression in breast cancer
    Q.-F. Yang
    T. Sakurai
    L. Shan
    Z. Yu
    G. Yoshimura
    T. Suzuma
    T. Tamaki
    T. Umemura
    M. Nakamura
    Y. Nakamura
    I. Mori
    K. Kakudo
    Journal of Human Genetics, 2000, 45 : 363 - 366
  • [48] Novel polymorphisms of prostate-specific antigen (PSA) gene associated with PSA mRNA expression in breast cancer
    Yang, QF
    Sakurai, T
    Shan, L
    Yu, ZG
    Yoshimura, G
    Suzuma, T
    Tamaki, T
    Umemura, T
    Nakamura, M
    Nakamura, Y
    Mori, I
    Kakudo, K
    JOURNAL OF HUMAN GENETICS, 2000, 45 (06) : 363 - 366
  • [49] Pathological factors evaluating prostate cancer
    Yu, Y. P.
    Luo, J-H.
    HISTOLOGY AND HISTOPATHOLOGY, 2007, 22 (11) : 1291 - 1300
  • [50] Expression of the survivin gene in prostate cancer: Correlation with clinicopathological characteristics, proliferative activity and apoptosis
    Kishi, H
    Igawa, M
    Kikuno, N
    Yoshino, T
    Urakami, S
    Shiina, H
    JOURNAL OF UROLOGY, 2004, 171 (05): : 1855 - 1860
12345